Angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensin II type 1 receptor (AT1R) gene polymorphism and its association with preeclampsia in Chinese women

Hypertension in Pregnancy

Volumn 26, Issue 3, 2007, Pages 293-301

  Li, Hua ^a   Ma, Yuyan ^a   Fu, Qingzhao ^a   Wang, Leiyi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Angiotensin II type 1 receptor; Gene; Polymorphism; Preeclampsia; Renal impact

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; UREA; URIC ACID;

ADULT; ANALYTIC METHOD; ANGIOTENSIN 1 RECEPTOR GENE; ANGIOTENSIN CONVERTING ENZYME GENE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANT WOMAN; PROTEINURIA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; KIDNEY; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 34548080694     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701413676     Document Type: Article

References (22)

1. Dietl J. The pathogenesis of pre-eclampsia: new aspects. J Perinat Med. 2000; 28:464-471.
2. Jeunemaitre X, Lifton R, Hunt SC, et al. Molecular basis of hypertension: Role of angiotensinogen. Cell 1992; 71:169-180.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
4. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71:169-180.
5. Sugimoto K, Katsuya T, Ohkubo T, Hozawa A, Yamamoto K, Matsuo A, Rakugi H, Tsuji I, Imai Y, Ogihara T. Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 2004; 27:551-556.
6. Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ, U.K. Prospective Diabetes Study. XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48:1907-1911.
7. Giner V, Poch E, Bragulat E, Oriola J, Gonzalez D, Coca A, De La Sierra. Reninangiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension 2000; 35:512-517.
8. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992; 20(6):1433.
9. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993; 4:59-61.
10. Morgan T, Craven C, Lalouel JM, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999; 180:95-102.
11. Tamura T, Johanning GL, Goldenberg R, Johnston KE, DuBard MB. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome. Obstet Gynecol 1996; 88:497-502.
12. Morgan L, Foster F, Hayman R, Crawshaw S, Baker PN, Broughton Pipkin F, Kalsheker N. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and preeclamptic pregnancies. J Hyperten 1999; 17:765-768.
13. Doria A, Ji L, Warram JH, Krolewski AS. DdeI polymorphism in the AGTR1 gene. Hum Mol Genet 1994; 3:1444.
14. Sutherland A, Cooper DW, Howie PW, Liston WA, MacGillivray I. The incidence of severe preeclampsia amongst mothers and mothers in-law of preeclamptic and controls. Br J Obstet Gynaecol 1981; 88:785-791.
15. ACOG technical bulletin. Hypertension in pregnancy. Number 219 - January 1996. Int J Gynaecol Obstet. 1996 May; 53(2):175-183.
16. van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, Smulders Y, Tarnow L, Donker AJ, Bilo HJ, Stehouwer CD. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 2000; 15:1000-1007.
17. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989; 320:1161-1165.
18. Earle K, Walker J, Hill C, Viberti G. Familial clustering of cardiovascular disease in patients with insulin dependent diabetes and nephropathy. N Engl J Med. 1992; 326:673-677.
19. Freire MB, Ferreira SR, Vivolo MA, Oliveira JM, Zanella MT, Familial hypertension and albuminuria in normotensive type I diabetic patients. Hypertension 1994; 23 (Suppl I):1256-1258.
20. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F, An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
21. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J, Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18:983-985.
22. Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow CC, Cockram CS, Chan JC. Prognostic effect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2005; 28:348-354.